| Queen's University, Ph.D. | |
| Chemistry |
Dr. Donini has 10 years experience in drug discovery, optimization and development and has lead the discovery, selection and advancement of Inimex’ lead drug candidate, IMX942. Prior to joining Inimex, Dr. Donini was involved in drug discovery and development at Kinetek Pharmaceuticals, managing a key program with an external partner, as well as initiating and managing a team providing informatics analysis and support to the company at large.
